Soligenix Announces Recent Accomplishments and Year End 2024 Financial Results
Hand-out
Press Releases
March 21, 2025

Soligenix Announces Recent Accomplishments and Year End 2024 Financial Results

PRINCETON, N.J., March 21, 2025 /PRNewswire/ -- Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where

bradford

The Bradford Era

Local & Social